Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Fortress Biotech (FBIO) over the last 13 years, with Q2 2025 value amounting to $26.9 million.

  • Fortress Biotech's Shares Outstanding (Weighted Average) rose 4674.65% to $26.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $26.9 million, marking a year-over-year increase of 4674.65%. This contributed to the annual value of $20.8 million for FY2024, which is 15625.17% up from last year.
  • As of Q2 2025, Fortress Biotech's Shares Outstanding (Weighted Average) stood at $26.9 million, which was up 4674.65% from $26.5 million recorded in Q1 2025.
  • In the past 5 years, Fortress Biotech's Shares Outstanding (Weighted Average) ranged from a high of $88.7 million in Q2 2022 and a low of $5.9 million during Q4 2022
  • Over the past 5 years, Fortress Biotech's median Shares Outstanding (Weighted Average) value was $20.2 million (recorded in 2024), while the average stood at $37.3 million.
  • In the last 5 years, Fortress Biotech's Shares Outstanding (Weighted Average) plummeted by 9274.79% in 2022 and then skyrocketed by 16267.77% in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Shares Outstanding (Weighted Average) stood at $81.7 million in 2021, then plummeted by 92.75% to $5.9 million in 2022, then surged by 36.89% to $8.1 million in 2023, then skyrocketed by 156.25% to $20.8 million in 2024, then increased by 29.33% to $26.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $26.9 million in Q2 2025, compared to $26.5 million in Q1 2025 and $20.8 million in Q4 2024.